Assessing the European Electric-Mobility Transition: Emissions from Electric Vehicle Manufacturing and Use in Relation to the EU Greenhouse Gas Emission Targets.

The European Union (EU) has set a 37.5% GHG reduction target in 2030 for the mobility sector, relative to 1990 levels. This requires increasing the share of zero-emission passenger vehicles, mainly in the form of electric vehicles (EVs). This study calculates future GHG emissions related to passenger vehicle manufacturing and use based on stated policy goals of EU Member States for EV promotion. Under these policies, by 2040 the stock of EVs would be about 73 times larger than those of 2020, contributing to a cumulative in-use emission reduction of 2.0 gigatons CO2-eq. Nevertheless, this stated EV adoption will not be sufficiently fast to reach the EU's GHG reduction targets, and some of the GHG environmental burdens may be shifted to the EV battery manufacturing countries. To achieve the 2030 reduction targets, the EU as a whole needs to accelerate the phase-out of internal combustion engine vehicles and transit to e-mobility at the pace of the most ambitious Member States, such that EVs can comprise at least 55% of the EU passenger vehicle fleet in 2030. An accelerated decarbonization of the electricity system will become the most critical prerequisite for minimizing GHG emissions from both EV manufacturing and in-use stages.

[Heat-sensitive moxibustion for migraine without aura: a randomized controlled trial].

OBJECTIVE: To compare the clinical effect between heat-sensitive moxibustion and mild moxibustion for migraine without aura. METHODS: A total of 54 patients with migraine without aura were randomized into an observation group (27 cases, 2 cases dropped off) and a control group (27 cases, 2 cases dropped off). The basic western medication treatment was adopted in the two groups. In the control group, mild moxibustion was applied at Shuaigu (GB 8), Fengchi (GB 20) and Yanglingquan (GB 34) on the affected side. In the observation group, the frequent acupoint areas of the affected side i.e. Shuaigu (GB 8), Fengchi (GB 20), Taiyang (EX-HN 5), Taichong (LR 3), Yanglingquan (GB 34) were determined, 3 acupoints with strong heat-sensitive sensation were selected each time and mild moxibustion was adopted. The treatment was given once a day, 5 times of treatment was as one course and 2 courses were required in the two groups. Before and after treatment, the scores of migraine symptom, visual analogue scale (VAS), migraine specific quality of life questionnaire (MSQ) were observed, and the clinical efficacy was evaluated after treatment in the two groups. RESULTS: After treatment, the scores of migraine symptom and VAS were decreased compared with those before treatment (P<0.01), while the MSQ scores were increased compared with those before treatment (P<0.01) in the two groups. After treatment, the scores of migraine symptom and VAS in the observation group were lower than those in the control group (P<0.05), while the MSQ score in the observation group was higher than that in the control group (P<0.01). The total effective rate was 92.0% (23/25) in the observation group, which was superior to 72.0% (18/25) in the control group (P<0.05). CONCLUSION: Both heat-sensitive moxibustion and mild moxibustion can effectively alleviate the clinical symptoms, improve the headache degree and life quality in patients with migraine without aura, the clinical efficacy of heat-sensitive moxibustion is superior to that of mild moxibustion.